US FDA grants orphan drug status to mexiletine hydrochloride: Lupin
NEW DELHI: Pharma major Lupin on Monday said the US health regulator has granted orphan drug designation (ODD) to mexiletine hydrochloride for the treatment of myotonic disorders. The Mumbai-based company’s drug NaMuscula (mexiletine hydrochloride) is the first and only licensed product to treat myotonia in adults with non-dystrophic myotonic (NDM) disorders. The company has already […]